ZielBio is an early-stage biotechnology company that identifies novel high-value disease targets and develops therapeutic interventions to improve patient outcomes. Its proprietary drug discovery platform Zielfind combines the power of functional, high throughput screening with large content data analytics to identify high-value targets. They havea promising pipeline of therapies and targets, including lead compound ZB131, a proprietary humanized monoclonal antibody against cell surface plectin (CSP) a cancer target identified through Zielfind.ZielBio was founded in 2011 and is based in Charlottesville, Virginia, United States.

Biotechnology

Health Care

Therapeutics

ZielBio, Inc.

ZielBio, Inc.

Org chart

Similar companies